The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1974, 112: 1477-1487.
Copyright © 1974 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Plata, F.
Right arrow Articles by Levy, J. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Plata, F.
Right arrow Articles by Levy, J. P.

Comparative in Vitro Studies on Effector Cell Diversity in the Cellular Immune Response to Murine Sarcoma Virus (MSV)-Induced Tumors in Mice1

Fernando Plata, Elisabeth Gomard, Jean Claude Leclerc and Jean Paul Levy

From the Laboratoire d'Immunologie des Tumeurs, Institut de Recherches sur les Maladies du Sang, Hópital Saint Louis, 75010 Paris, France

Abstract

The cellular immune response to murine sarcoma virus (MSV)-induced tumors in B6 mice was studied in vitro with two techniques: the 51Cr release test (CRT) and the microcytotoxicity assay (MA). The analysis of the effector cell nature in each of these assays showed that only thymus-dependent (T) cells are effector cells in CRT, while both T and non-T cells can be effector cells in MA. Comparative studies of the same lymphoid cell preparations demonstrated that the T cells revealed in MA might not be identical with the T cells whose activity is measured in CRT.

Footnotes

1 This work was supported by contracts from I.N.S.E.R.M. and D.G.R.S.T.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.